NeuroPace (NPCE) Cash & Current Investments (2020 - 2026)

NeuroPace has reported Cash & Current Investments for 7 years, with the latest figure at $51.7 million in Q2 2026.

• On a quarterly basis, Cash & Current Investments fell 16.8% year-over-year to $51.7 million in Q2 2026; TTM through Jun 2026 was $51.7 million, a 16.8% decrease from a year earlier, with the FY2025 full-year figure at $61.1 million, up 15.74% from the prior year.
• Cash & Current Investments was $51.7 million for Q2 2026 at NeuroPace, down from $54.0 million in the prior quarter.
• The five-year high for Cash & Current Investments was $103.2 million in Q1 2022, with the low at $51.7 million in Q2 2026.
• Average Cash & Current Investments over 5 years is $66.5 million, with a median of $61.7 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments soared 237.95% in 2022, then plunged 34.47% in 2023.
• Over 5 years, Cash & Current Investments stood at $77.4 million in 2022, then slipped by 14.15% to $66.5 million in 2023, then fell by 20.61% to $52.8 million in 2024, then rose by 15.74% to $61.1 million in 2025, then declined by 15.33% to $51.7 million in 2026.
• The last three Cash & Current Investments figures came in at $51.7 million (Q2 2026), $54.0 million (Q1 2026), and $61.1 million (Q4 2025), per Business Quant data.